Wedge Industrial Co.,Ltd. (SHE:000534)
25.00
+0.20 (0.81%)
Jul 21, 2026, 3:04 PM CST
Wedge Industrial Revenue
Wedge Industrial had revenue of 359.78M CNY in the quarter ending March 31, 2026, with 7.39% growth. This brings the company's revenue in the last twelve months to 1.32B, up 17.08% year-over-year. In the year 2025, Wedge Industrial had annual revenue of 1.29B with 19.62% growth.
Revenue (ttm)
1.32B
Revenue Growth
+17.08%
P/S Ratio
9.17
Revenue / Employee
914.64K
Employees
1,438
Market Cap
12.06B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.29B | 211.64M | 19.62% |
| Jan 1, 2025 | 1.08B | 97.43M | 9.93% |
| Dec 31, 2023 | 981.44M | 187.60M | 23.63% |
| Jan 1, 2023 | 793.84M | 137.59M | 20.97% |
| Jan 1, 2022 | 656.26M | 103.69M | 18.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Shyndec Pharmaceutical | 8.82B |
| Zhejiang Medicine | 8.82B |
| Zhejiang CONBA Pharmaceutical | 6.69B |
| Guobang Pharma | 6.09B |
| Shenzhen Hepalink Pharmaceutical Group | 5.42B |
| Zhejiang Jingxin Pharmaceutical | 4.04B |
| Nanjing King-Friend Biochemical Pharmaceutical | 4.03B |
| Henan Lingrui Pharmaceutical | 3.96B |
Wedge Industrial News
- 3 months ago - Wedge Industrial Quarterly report: Q1 2026 - Filings
- 3 months ago - Wedge Industrial Annual report: Q4 2025 - Filings
- 9 months ago - Wedge Industrial Quarterly report: Q3 2025 - Filings
- 11 months ago - Wedge Industrial Quarterly report: Q2 2025 - Filings